Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who can speak and read English
- People who are able to give their informed consent to participate
- People who received treatment for a cancer that was not in the brain or spinal cord within the last three years, where that treatment included chemotherapy
- People who have noticed memory, concentration, or thinking difficulties since their cancer treatment
- People who either have a current diagnosis of type 2 diabetes (confirmed by specific blood sugar test results or by taking medication to manage blood sugar), or people who have no type 2 diabetes diagnosis (confirmed by specific blood sugar test results showing normal levels) — a doctor's records are the preferred way to confirm this
- People who own a smartphone and/or a computer with internet access
- People who are willing to take part in a 12-week physical activity program delivered remotely
Who may not be able to join:
- People whose answers on a standard physical activity safety questionnaire (the PAR-Q+) suggest that physical activity may not be safe for them, unless a signed doctor's note is provided — certain answers about blood pressure and blood sugar control may still allow participation (confirm with trial site)
- People who are already doing 75 minutes or more of vigorous exercise per week, 150 minutes or more of moderate exercise per week, or an equivalent combination of both, over the past 3 months
- People who are currently pregnant, planning to become pregnant during the study, or currently incarcerated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zachary C Pope, PhD, University of Oklahoma Health Sciences
Phone: 405-271-8001
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Middle Cerebral Artery Velocity; Cerebrovascular Resistance; Cerebrovascular Conductance; Cerebrovascular Pulsatility; Dynamic Cerebral Autoregulation; Cognitive Function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.